迈得医疗董事会审议通过2025年三季报 核心募投项目延期一年至2026年11月

Core Points - The company held its fifth board meeting on October 27, 2025, where multiple resolutions were passed, including the approval of the Q3 2025 report and the postponement of fundraising projects [1][2][3] Group 1: Board Meeting Overview - The board meeting was legally valid with all seven directors present, as notified via email on October 22, 2025 [2] - The meeting was chaired by Chairman Lin Junhua, ensuring compliance with legal requirements [2] Group 2: Q3 2025 Report Approval - The board approved the Q3 2025 report, which has been disclosed on the Shanghai Stock Exchange website for investors to review detailed financial data and operational conditions [3] - The resolution received unanimous support with 7 votes in favor and no opposition or abstentions [3] Group 3: Fundraising Project Postponement - The board agreed to extend the timeline for the "Annual Production of 35 Medical Equipment Combination Intelligent Devices Expansion Project" from November 2025 to November 2026, effectively delaying the project by one year [4] - This project is a core capacity expansion initiative focused on the medical equipment sector, and the decision was also unanimously approved with 7 votes in favor [4] - Detailed reasons and impacts of the project delay have been disclosed in a separate announcement available on the Shanghai Stock Exchange website [4]